SINT (SINTX Technologies) Prakiraan pendapatan perusahaan
Sintx Technologies (SINT) is currently shifting its strategic direction, moving from private implants toward mass B2B supplies of antibacterial components. The company's expected realization level, as shown on this GURU.Markets chart, captures demand dynamics where 0.00 serves as the current parameter value. The model relies on external powder suppliers and contract ceramics manufacturing, delegating logistics and service to specialized partners.
Rincian analitis lan laporan data perusahaan SINTX Technologies (SINT)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Sintx Technologies|SINT - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Sintx Technologies|SINT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Sintx Technologies Inc|SINT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sintx Technologies|Indikator likuiditas cepet sintx.com
- statistik bathi lan rasio pasar:
SINT - Bathi pungkasan|Proyeksi bathi mangsa ngarep Sintx Technologies|SINT - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Sintx Technologies|SINT - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sintx Technologies Inc|SINT - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Sintx Technologies|SINT - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sintx.com|SINT - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sintx Technologies
- data dodolan lan asil:
Analisis fundamental perusahaan:Sintx Technologies, Inc.
Sintx Technologies (SINT) supplies high-tech biocompatible ceramics for surgical and industrial applications. This metric compares market forecasts with actual data, revealing operational shifts within the business. Investors use this metric to assess management efficiency and the resilience of demand for materials. This price action allows for the timely recognition of trend reversals, thereby minimizing risks. By analyzing the company's prospective sales volume, one can accurately balance the asset's potential yield.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BSX (Boston Scientific)|EW (edwards.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ResMed RMD|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan CooperSurgical|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Group, Inc.) - Prakiraan volume dodolan|Alphatec Holdings (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AORT|Volume dodolan mangsa ngarep perusahaan Enovis Inc. ENOV|Prakiraan volume dodolan IART (Integra LifeSciences)|Prakiraan volume dodolan establishmentlabs.com ESTA|BBNX - Prakiraan pendapatan perusahaan|IRMD: Prakiraan pendapatan perusahaan|EMBC (Embecta Inc.) - Volume dodolan mangsa ngarep perusahaan|Tandem Corp - Pendapatan mangsa ngarep perusahaan|AXGN (AxoGen, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan si-bone.com SIBN|Prakiraan pendapatan perusahaan Orthofix (OFIX)|Bioventus Inc (BVS) - Prakiraan dodolan perusahaan|OrthoPediatrics - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Treace Corp TMCI|Strata Critical Medical Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan carlsmed.com CARL|RxSight (RXST) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CLPT (ClearPoint Neuro)|Prakiraan pendapatan perusahaan Stereotaxis Corp|Volume dodolan mangsa ngarep perusahaan Neuronetics, Inc (STIM)|Prakiraan volume dodolan SGHT|OBIO - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Anika Therapeutics, Inc. ANIK|NSPR: Prakiraan pendapatan perusahaan|ZJYL: Volume dodolan mangsa ngarep perusahaan|Vivani Medical, Inc. - Prakiraan volume pendapatan perusahaan|xtantmedical.com (XTNT) - Prakiraan pendapatan perusahaan|NMTC - Dodolan mangsa ngarep perusahaan|MODD (Modular Medical Inc) - Prakiraan volume dodolan|Myomo Inc. (MYO) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Envoy Medical, Inc (COCH)|Vivos Therapeutics Inc - Prakiraan pendapatan perusahaan|enVVeno Medical - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan TNON (tenonmed.com)|LFWD: Volume dodolan mangsa ngarep perusahaan|AMIX (Autonomix Medical, Inc.) - Prakiraan pendapatan perusahaan|IVF (INVO Bioscience, Inc.) - Volume dodolan mangsa ngarep perusahaan|Bone Biologics Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan AXNX|BIOL (biolase.com) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan DYNT|FNA - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan INVO (INVO Bioscience)
